+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

" Kala-Azar is a Dishonest Disease ": Community Perspectives on Access Barriers to Visceral Leishmaniasis (Kala-Azar) Diagnosis and Care in Southern Gadarif, Sudan



" Kala-Azar is a Dishonest Disease ": Community Perspectives on Access Barriers to Visceral Leishmaniasis (Kala-Azar) Diagnosis and Care in Southern Gadarif, Sudan



American Journal of Tropical Medicine and Hygiene 98(4): 1091-1101



Early diagnosis and treatment is the principal strategy to control visceral leishmaniasis (VL), or kala-azar in East Africa. As VL strikes remote rural, sparsely populated areas, kala-azar care might not be accessed optimally or timely. We conducted a qualitative study to explore access barriers in a longstanding kala-azar endemic area in southern Gadarif, Sudan. Former kala-azar patients or caretakers, community leaders, and health-care providers were purposively sampled and thematic data analysis was used. Our study participants revealed the multitude of difficulties faced when seeking care. The disease is well known in the area, yet misconceptions about causes and transmission persist. The care-seeking itineraries were not always straightforward: "shopping around" for treatments are common, partly linked to difficulties in diagnosing kala-azar. Kala-azar is perceived to be "hiding," requiring multiple tests and other diseases must be treated first. Negative perceptions on quality of care in the public hospitals prevail, with the unavailability of drugs or staff as the main concern. Delay to seek care remains predominantly linked to economic constraint: albeit treatment is for free, patients have to pay out of pocket for everything else, pushing families further into poverty. Despite increased efforts to tackle the disease over the years, access to quality kala-azar care in this rural Sudanese context remains problematic. The barriers explored in this study are a compelling reminder of the need to boost efforts to address these barriers.

(PDF emailed within 1 workday: $29.90)

Accession: 065216496

Download citation: RISBibTeXText

PMID: 29488462


Related references

Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India. Indian Journal of Medical Research 122(6): 485-490, 2006

Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. American Journal of Tropical Medicine and Hygiene 51(6): 826-836, 1994

Endemic kala-azar in eastern Sudan: post-kala-azar dermal leishmaniasis. American Journal of Tropical Medicine and Hygiene 52(4): 299-305, 1995

Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan. Clinical Infectious Diseases 38(5): 612-619, 2004

Visceral kala-azar associated with post-kala-azar dermal leishmaniasis. Journal of the Association of Physicians of India 37(2): 191, 1989

Post-kala-azar dermal leishmaniasis and visceral leishmaniasis in a child--or is it para-kala-azar dermal leishmaniasis?. International Journal of Dermatology 48(9): 1027-1028, 2009

Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis). Transactions of the Royal Society of Tropical Medicine and Hygiene 78(3): 391-398, 1984

Spectrum of skin lesions of post-kala-azar dermal leishmaniasis in kala-azar endemic areas of Bangladesh. Mymensingh Medical Journal 21(3): 529-532, 2012

Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients. Bmc Infectious Diseases 14: 662, 2015

Modulation of the cell-mediated immune response in kala-azar and post-kala-azar dermal leishmaniasis in relation to chemotherapy. Annals of Tropical Medicine and Parasitology 82(1): 27-34, 1988

DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal leishmaniasis in humans. Journal of Clinical Microbiology il; 42(4): 1739-1741, 2004

Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas?. Bulletin of the World Health Organization 70(3): 341-346, 1992

Immunoglobulin G subclass-specific antileishmanial antibody responses in Indian kala-azar and post-kala-azar dermal leishmaniasis. Clinical and Diagnostic Laboratory Immunology 2(3): 291-296, 1995

AmBisome for Kala-azar and Post-Kala-Azar Dermal Leishmaniasis: An essential option but not a universal solution. Clinical Infectious Diseases 2018, 2018

Characterization of Leishmania isolated from patients with kala-azar and post kala-azar dermal leishmaniasis in Bangladesh. Transactions of the Royal Society of Tropical Medicine and Hygiene 89(3): 331-332, 1995